aTYR PHARMA INC
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · San Diego, CA
ATYR chart
What traders are saying about $ATYR
Latest postsaTYR PHARMA INC news
- aTyr Pharma implements one-for-forty split. aTyr Pharma stock is valued at USD 11.3 million
ad-hoc-news.de ·
- Form 8K aTyr Pharma Inc For: 27 October By Investing.com
Investing.com Nigeria ·
- aTyr Pharma announces 1-for-40 reverse stock split effective October 28
Investing.com ·
- aTyr Pharma to implement 1-for-40 reverse stock split
Investing.com ·
- aTyr Pharma Announces One-for-40 Reverse Stock Split
Yahoo Finance ·
- About 100.5 million aTyr shares will be combined into about 2.5 million
Stock Titan ·
- aTyr Pharma (ATYR) Slips 2.94% to $0.17 as Penny Stock Tests Support Near $0.16 - Runaway Gap
https://www.siam.in/ ·
- aTyr Pharma has November 5, 2026 results. aTyr Pharma stock sits below EUR 0.80 high
ad-hoc-news.de ·
- aTyr Pharma, Inc. Estimates – NASDAQ:ATYR
TradingView ·
- aTyr Pharma stock: EUR 0.16 puts aTyr Pharma stock 196.30 percent above Frankfurt close
ad-hoc-news.de ·
- aTyr Pharma, Inc. Stock 12‑Month Price Target Raised to $3.2, Implies 1757% Upside
TradingView ·
- aTyr Pharma (ATYR) Stock Rises 2.08% to $0.18: Key Levels to Watch - Volume Oscillator
https://www.siam.in/ ·
aTYR PHARMA INC key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $190,000 | $235,000 | $353,000 | $10.4M |
| Net income | -$74.1M | -$64.0M | -$50.4M | -$45.3M |
| Diluted EPS | $-0.80 | $-0.86 | $-0.94 | $-1.60 |
| Total assets (year end) | $93.0M | $96.8M | $120.7M | $95.8M |
| Cash and equivalents (year end) | $10.7M | $11.1M | $22.5M | $10.0M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About aTYR PHARMA INC
- Ticker
- ATYR (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1339970
Frequently asked questions
What exchange is aTYR PHARMA INC listed on?
aTYR PHARMA INC trades on the Nasdaq under the ticker symbol ATYR.
What industry is aTYR PHARMA INC in?
aTYR PHARMA INC is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is aTYR PHARMA INC headquartered?
aTYR PHARMA INC's business address on file with the SEC is in San Diego, CA.
When does aTYR PHARMA INC's fiscal year end?
aTYR PHARMA INC's fiscal year ends on December 31.
How much revenue did aTYR PHARMA INC report?
aTYR PHARMA INC reported $190,000 in revenue for calendar year 2025, according to its SEC filings.